Skip Navigation


Steven R. Feldman, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

282 Ratings

Steven R. Feldman, M.D., Ph.D.

Professor, Dermatology

Clinical Interests

Dermatology (general), Psoriasis, Dermatopathology

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-3926
Department: 336-716-3926


Insurance Accepted »

Media Medical Expert »

Additional Languages


Education & Training

  • B.A., University of Chicago, 1980
  • M.D., Duke University School of Medicine, 1985
  • Ph.D., Duke University, 1985
  • Internship, Medicine, Duke University Hospital, 1987
  • Residency, Dermatology, North Carolina Mem Hosp, 1990
  • Residency, Dermatopathology, Med U Sc Teaching Hosps, 1991

Board Certifications

  • American Board of Dermatology, Dermatology
  • American Board of Dermatology, Dermatopathology


  • Am Soc Of Dermatopathology
  • Am Academy Of Dermatology

NPI Number

  • 1720063175
Steven R. Feldman, M.D., Ph.D.

Doctor Rating

4.5 out of 5

282 Ratings

Steven R. Feldman, M.D., Ph.D.

Professor, Dermatology
Social Sciences & Health Policy

Research Interests

Psoriasis; Dermatologic Agents; Dermatology; Acne Vulgaris; Skin Diseases
More »

Contact Information

Request An Appointment

Academic: 336-716-7740 | Department: 336-716-3926


Media Medical Expert »

Recent Publications

The safety of treatments used in pyoderma gangrenosum. Feldman SR, Lacy FA, Huang WW.. Expert Opin Drug Saf. 2018;17(1):55-61.

Adherence in dermatology. Ahn CS, Culp L, Huang WW, Davis SA, Feldman SR.. J Dermatolog Treat. 2017;28(2):94-103.

Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. Alghanem N, Abokwidir M, Fleischer AB Jr, Feldman SR, Alghanem W.. J Dermatolog Treat. 2017;28(2):119-128.

Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis. Armstrong AW, Feldman SR, Korman NJ, Meng X, Guana A, Nyirady J, Herrera V, Zhao Y.. J Dermatolog Treat. 2017;28(3):200-205.

Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials. Thaci D, Kimball A, Foley P, Poulin Y, Levi E, Chen R, Feldman SR.. J Eur Acad Dermatol Venereol. 2017;31(3):498-506.

Long-term adherence to topical psoriasis treatment can be abysmal: a one-year randomized intervention study using objective electronic adherence monitoring. Alinia H, Moradi Tuchayi S, Smith JA, Richardson IM, Bahrami N, Jaros SC, Sandoval LF, Farhangian ME, Anderson KL, Huang KE, Feldman SR.. Br J Dermatol. 2017;176(3):759-764.

Pharmacoeconomic considerations in treating actinic keratosis: an update. Vale SM, Hill D, Feldman SR.. Pharmacogenomics. 2017;35(2):177-190.

Relative versus absolute risk of comorbidities in patients with psoriasis. Saleem MD, Kesty C, Feldman SR.. J Am Acad Dermatol. 2017;76(3):531-537.

Reply to: "Is treatment of acne as simple as encouraging primary care physicians to prescribe more retinoids?" [reply to letter]. Pena S, Hill D, Feldman SR.. J Am Acad Dermatol. 2017;76(1):e39.

Advances in psoriasis. Smith J, Cline A, Feldman SR.. South Med J. 2017;110(1):65-75.

Chemical pharmacotherapy options for managing adult acne. Vera N, Patel N, Cardwell LA, Saleem M, Feldman SR.. Expert Opin Pharmacother. 2017;18(3):263-273.

Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Feldman SR, Vrijens B, Gieler U, Piaserico S, Puig L, van de Kerkhof P.. Am J Clin Dermatol. 2017;18(2):253-271.

Risk versus benefit or risk versus risk: risk aversion in the medical decision making process [editorial]. Oussedik E, Anderson MS, Feldman SR.. J Dermatolog Treat. 2017;28(1):1-2.

Increasing adherence with topical agents for atopic dermatitis. Patel NU, D'Ambra V, Feldman SR.. Am J Clin Dermatol. 2017;18(3):323-332.

Interleukin-31 pathway and its role in atopic dermatitis: a systematic review. Saleem MD, Oussedik E, D'Amber V, Feldman SR.. J Dermatolog Treat. 2017;28(7):591-599.

Cost of diagnosing psoriasis and rosacea for dermatologists versus primary care physicians. Hill D, Feldman SR.. Cutis. 2017;99(2):134-136.

Recent advances in small molecule and biological therapeutic approaches in the treatment of psoriasis. Turbeville JG, Patel NU, Cardwell LA, Oussedik E, Feldman SR.. Clin Pharmacol Ther. 2017;102(1):70-85.

Dermatologists: collaborating with payers to optimize coverage policies. Amato DA, Malatestinic WN, Palmgren MC, Feldman SR.. J Drugs Dermatol. 2017;16(3):228-232.

Scalp psoriasis associated with central centrifugal cicatricial alopecia. Larson KN, Smith J, Cardwell LA, Feldman SR.. J Dermatol Dermatol Surg. 2017;21(1):31-34.

Treatment of atopic dermatitis in the United States: analysis of data from the National Ambulatory Medical Care Survey. McGregor SP, Farhangian ME, Huang KE, Feldman SR.. J Drugs Dermatol. 2017;16(3):250-255.

Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. Feldman SR, Tian H, Gilloteau I, Mollon P, Shu M.. BMC Health Serv Res. 2017;17(1):337.

Economic impact of above-label dosing with etanercept, adalimumab, or ustekinumab in patients with psoriasis. Feldman SR, Zhao Y, Zhou H, Herrera V, Tian H, Li Y.. J Manag Care Spec Pharm. 2017;23(5):583-589.

Psoriasis, depression, and inflammatory overlap: a review. Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, Feldman SR.. Am J Clin Dermatol. 2017;18(5):613-620.

Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis. Saleem MD, Feldman SR.. J Dermatolog Treat. 2017;():.

Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. Saleem MD, Negus D, Feldman SR.. J Dermatolog Treat. 2017;():.

Physicians report sleep apnea infrequently in older and older vulnerable adults. Namen AM, Forest DJ, Huang KE, Feldman SR, Hazzard WR, Peters SP, Haponik EF.. J Am Geriatr Soc. 2017;65(9):2023-2028.

Dupilumab for atopic dermatitis [editorial comment]. Strowd LC, Feldman SR.. Lancet. 2017;389(10086):2265-2266.

Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs. Asche CV, Kim M, Feldman SR, Zografos P, Lu M.. J Med Econ. 2017;20(9):1000-1006.

Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease. Hohenberger M, Cardwell LA, Oussedik E, Feldman SR.. J Dermatolog Treat. 2017;():.

Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne [commentary]. Davis SA, Himmler S, Feldman SR.. Dermatol Online J. 2017;23(5):.

Web app based patient education in psoriasis - a randomized controlled trial. Hawkins SD, Barilla S, Feldman SR.. Dermatol Online J. 2017;23(4):.

Patient perceptions of text-messages, email, and video in dermatologic surgery patients. Hawkins SD, Barilla S, Williford PWM, Feldman SR, Pearce DJ.. Dermatol Online J. 2017;23(4):.

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. Al Sawah S, Foster SA, Goldblum OM, Malatestinic WN, Zhu B, Shi N, Song X, Feldman SR.. J Med Econ. 2017;20(9):982-990.

Common dermatologic diagnoses in pediatric emergency department population [abstract]. Cardwell L, Nadkarni A, Mahler S, Feldman S.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB76.

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis [abstract]. Feldman S, Green L, Kimball AB, Siu K, Zhao Y, Herrera V, Alexis A.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB227.

Hesitancy toward adalimumab therapy decreases in psoriasis and psoriatic arthritis patients enrolled in a nurse care management program [abstract]. Feldman SR, Kane SV, Collins RM, Shortess M, Scrimager D, Dziedzic JL, Valdecantos WC.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB152.

Characteristics of patients newly initiating ustekinumab, adalimumab, secukinumab, apremilast or methotrexate for plaque psoriasis [abstract]. Lee S, Carroll C, Pericone C, Tunceli O, Fakharzadeh S, Feldman S.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB66.

Do patient satisfaction surveys accurately evaluate provider behavior and predict provider compensation? [abstract]. Negus D, Tull R, Domeisen N, Huang W, Feldman S.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB103.

An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis [research letter]. Oussedik E, Cardwell LA, Patel NU, Onikoyi O, Feldman SR.. JAMA Dermatol. 2017;153(9):932-934.

Efficacy of tofacitinib in pediatric alopecia universalis [abstract]. Patel N, Oussedik E, Pichardo-Geisinger RO, Feldman S.. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB121.

The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis. Rajabi-Estarabadi A, Hasanzadeh H, Taheri A, Feldman SR, Firooz A.. J Dermatolog Treat. 2017;():.

Comorbidities in patients with psoriasis: the role of the dermatologist [editorial commentary]. Saleem MD, Feldman SR.. J Am Acad Dermatol. 2017;77(1):191-192.

Real-world burden of comorbidities in US patients with psoriasis. Shah K, Mellars L, Changolkar A, Feldman SR.. J Am Acad Dermatol. 2017;77(2):287-292.e4.

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability. Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR.. Patient Prefer Adherence. 2017;11():1143-1150.

Perspectives [editorial]. Feldman SR.. J Dermatolog Treat. 2017;28(5):373.

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis. Feldman SR, Green L, Kimball AB, Siu K, Zhao Y, Herrera V, Nyirady J, Alexis AF.. J Dermatolog Treat. 2017;28(8):716-721.

Incidence rates of comorbidities among patients with psoriasis in the United States [abstract]. Feldman SR, Hur P, Zhao Y, Tian H, Wei Z, Wang X, Herrera V.. Value Health. 2017;20(5):A155.

Adherence and persistence among US patients initiating secukinumab for the treatment of moderate to severe plaque psoriasis [abstract]. Feldman SR, Zhao Y, Gray S, Montejano LB, Lin F, Herrera V.. Value Health. 2017;20(5):A159.

Previous treatments for plaque psoriasis among US patients initiating secukinumab [abstract]. Feldman SR, Zhao Y, Gray S, Montejano LB, Lin F, Herrera V.. Value Health. 2017;20(5):A161.

Long-term treatment patterns among patients who developed moderate-to-severe psoriasis [abstract]. Feldman SR, Zhao Y, Hur P, Liu JS, Herrera V.. Value Health. 2017;20(5):A162.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Dermatology

Clinical Interests

Dermatology (general), Psoriasis, Dermatopathology
Steven R. Feldman, M.D., Ph.D.

Steven R. Feldman, M.D., Ph.D.

Professor, Dermatology
Social Sciences & Health Policy

Request An Appointment

Doctor Rating

4.5 out of 5

Steven R. Feldman, M.D., Ph.D.282 Ratings


Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
CP efforts to include in decisions
CP explanations of prob/condition
CP spoke using clear language
Friendliness/courtesy of CP
Likelihood of recommending CP
Patients' confidence in CP
Time CP spent with patient
Wait time at clinic

Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.


I was there for a yearly exam and did not require any type of treatment. There was no problem on getting a prescription for the face cream I use. I was very pleased with the visit to Dr Feldman's office and with him.


I contacted Dr. Feldman via MyWakeHealth with some concerns and here was very prompt and helpful.


Dr. Feldman is the perfect doctor. He is kind, caring, and determined, he listens and explains things well, he is, of course, a brilliant doctor, and I love his sense of humor. He spends a lot of time with me, so I can learn as much as I can about my extremely rare disease and together we can decide the best possible option. To anyone who thinks he doesn't care because he doesn't spend much time with you, I say be glad that he can look at you and know immediately what you have and what action needs to be taken. You might just be luckier than you think.


he was great


Dr. Feldman has a very big ego. He really wants the residents that are under him to know how smart he is. He really needs to work on his beside manner.


Even though he was not the provider that I normally see, (actually, he agreed to see me because of the distance that I drive and my provider had some medical issues), he was excellent. He displayed a sincere interest in me as an individual and my medical history. He was an attentive listener and answered all of my questions in terms that I could understand. He even took enough time to refuse a suggestion made by the resident doctor for a possible drug (this was not done in my presence. The resident doctor told me), because of possible side effects. I was very impressed and appreciative that Dr. Feldman took that much time to consider me as a 73 year-old individual.


very professional very impressed


Excellent! Friendly, Helpful, Cared! And was fun to chat with!


he had a very friendly manor


wonderful physician. I have already recommended Dr Feldman to several acquaintances.




All drs. and other, all were interested in what I had to say. Very caring and understanding.


Though I think Dr. Feldman is quite competent, I do feel he needs to be more mindful of how he treats patients. I am also an employee here so I know how importance it is to treat patients with respect and compassion.


I have seen this provider for a number of years. I would not want to see anyone else unless he retired! He's very knowledgeable and he shows he cares about me!


Dr. Feldman is always great. I had a family member with me & she was impressed by him as well.


*Dr. Feldman is the best he even wants you to check in on weekends to let him know if meds are working or not.


I think Dr. Feldman is far above what a patient expects in today's health care environment, which is full of obstacles. He's always friendly, understanding, incisive, and can explain a complex situation simply and to the point.


Dr. Feldman is great. He was friendly, open and takes time for his patients. He even explained the test results himself and gave me his work number to call to speak directly with him if anything changes. I will definitely continue seeing Dr Feldman and also recommend him to any friends looking for a dermatologist.


I don't think I would drive 2 hrs in the future. Talking points were said too fast and my grasp of the content was somewhat compromised.


My time with Dr. Feldman was very brief. Most of my time spent was with a female Resident.


Dr. Feldman is a top notch doctor, who treats his patients with respect and kindness.


Dr. Feldman has earned my highest level of trust and appreciation since I first visited with Psoriasis. The positive effect his path of treatment has given me literally has allowed me a new outlook on life


great doctor with a wonderful friendly attitude.


Came in well after appointment time and only stayed in the room briefly


*Dr. Feldman is the best.


Could have benefited from more info on my diagnosis.


No bad experience at all.


sometimes I feel Feldman has a cavalier attitude & is not as thorough as needed when doing a skin cancer check, even though I have had 4 basal cell spots removed


This is the first provider/practice that I have dealt with so far that has shown sincere interest in actually making the problem better and not just going through an arbitrary list of things to try.


Dr. Feldman has been my doctor for many years. He takes excellent care of me, my family, and my friends. I highly recommend him to anyone who is seeking a kind and caring experienced doctor.


Did not seem to care about my opinions and personal experience with my medical problem.


Doctor basically dismissed the overall concern, only performed a biopsy at my request. Biopsy showed signs of cancer.


*Dr. Feldman said we are going outside & put our heads together to help your problem and I have not seen him since that time 2-27-17.


Dr. Feldman is a wonderful doctor. He is my go-to for any type of problem that I have experienced because he always explains and fixes any problems that I may experience.


Dr Feldman always shows genuine concern for your well being.


Dr Feldman was very friendly and put our whole family at ease. We left his office hopeful regarding our daughters future.


knowledgeable physician


Dr. Feldman has a lot of patients...thank goodness I'm one of them. With my childhood skin problems I know when a dermatologist knows what he's talking about. He's good.


*Dr. Feldman is a very friendly, concerned doctor. Very good.


he never touched my scalp. did not think he thought my condition was serious enough for him


Best doctor any patient could ever hope to have. Excellent in every way. Kind, patient, and experienced. I always recommend him to family and friends and have gotten lots of positive feedback. The best thing about Dr. Feldman is that he truly does care about people and wants the best possible outcome for everyone.


Dr. Feldman is very professional and courteous and allows you to contact him with additional concerns or questions. It's hard in this age to find medical professionals that are this dedicated to the patient.


Seen for a dermatologic problem. Less than 10 seconds spent looking at my skin. I expressed concerns over continued symptoms and these were ignored. I asked if it was reasonable for me to expect to be symptom free,and this question was not addressed or answered.

Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.